81514-40-1

Basic information

• Product Name: 9-Benzyl-3-oxa-9-azabicyclo[3.3.1]nonan-7-one
• Synonyms: 9-Benzyl-3-oxa-9-azabicyclo[3.3.1]nonan-7-one;9-Benzyl-3-oxa-9-azabicyc...;N-benzyl-7-oxa-9-azabicyclononan-3-one;9-benzyl-3-oxa-9-azabicyclo[3.3.1]nonanone
• CAS NO: 81514-40-1
• Molecular Formula: C₁₄H₁₇NO₂
• Molecular Weight: 231
• Mol File: 81514-40-1.mol
• Article Data: 13

Chemical Properties

• Boiling Point: 371.1±42.0 °C(Predicted)
• Appearance: /
• Density: 1.170±0.06 g/cm3(Predicted)
• Storage Temp.: 2-8°C
• PKA: 6.01±0.20(Predicted)
• CAS DataBase Reference: 9-Benzyl-3-oxa-9-azabicyclo[3.3.1]nonan-7-one(CAS DataBase Reference)
• NIST Chemistry Reference: 9-Benzyl-3-oxa-9-azabicyclo[3.3.1]nonan-7-one(81514-40-1)
• EPA Substance Registry System: 9-Benzyl-3-oxa-9-azabicyclo[3.3.1]nonan-7-one(81514-40-1)

Safety Data

• Hazardous Substances Data: 81514-40-1(Hazardous Substances Data)

Usage

General Description

9-Benzyl-3-oxa-9-azabicyclo[3.3.1]nonan-7-one, also known as BON, is a chemical compound belonging to the class of bicyclic compounds. It is a heterocyclic compound containing a unique arrangement of carbon, hydrogen, nitrogen, and oxygen atoms. BON has potential applications in medicinal chemistry and drug development, particularly in the synthesis of novel pharmaceutical compounds. Its distinct structure and functional groups make it a subject of interest in organic synthesis and chemical research. The compound's properties and reactivity make it a valuable building block for the creation of diverse molecular structures with potential biological activities.

Upstream product

• 542-05-2 acetonedicarboxylic acid 
• 7456-83-9 2,2'-oxybis(acetaldehyde) 
• 100-46-9 benzylamine 
• 56999-16-7 2-(2,2-diethoxyethoxy)-1,1-diethoxyethane 
• 1558-67-4 formic anhydride 
• 1085458-56-5 2-(2,2-diethoxyethoxy)-1,1-dimethoxyethane 
• 3287-99-8 benzylamine hydrochloride 
• 1126795-00-3 3-oxa-9-azabicyclo[3.3.1]nonan-7-one hydrochloride 
• 100-39-0 benzyl bromide 
• 502-50-1 4-Ketopimelic acid 
• 4358-64-9 cis-1,4-anhydroerythritol 
• 285-69-8 3,4-epoxytetrahydrofuran 
• 867-13-0 diethoxyphosphoryl-acetic acid ethyl ester 

Downstream Products

• 141380-03-2 N-benzyl-7-oxa-9-azabicyclo<3.3.1>nonane-3-carbonitrile 
• 926658-87-9 3-oxa-9-azabicyclo[3.3.1]nonan-7-one 
• 1085458-59-8 10-benzyl-8-oxa-3,10-diazabicyclo[4.3.1]decan-4-one 
• 1085458-61-2 tert-butyl 10-benzyl-8-oxa-3,10-diazabicyclo[4.3.1]decane-3-carboxylate 
• 1085458-68-9 tert-butyl 10-[2-(2H-1,2,3-triazol-2-yl)benzoyl]-8-oxa-3,10-diazabicyclo[4.3.1]decane-3-carboxylate 
• 1085458-32-7 3-(6-fluoroquinazolin-2-yl)-10-[2-(2H-1,2,3-triazol-2-yl)benzoyl]-8-oxa-3,10-diazabicyclo[4.3.1]decane 
• 1085458-63-4 10-benzyl-8-oxa-3,10-diazabicyclo[4.3.1]decane 
• 1085458-73-6 (1R,6S)-10-benzyl-8-oxa-3,10-diazabicyclo[4.3.1]decane 
• 1085458-75-8 (1S,6R)-10-benzyl-8-oxa-3,10-diazabicyclo[4.3.1]decane 
• 1085458-70-3 C₁₆H₁₉N₅O₂ 
• 1126795-00-3 3-oxa-9-azabicyclo[3.3.1]nonan-7-one hydrochloride 
• 280761-97-9 tert-butyl 7-oxo-3-oxa-9-azabicyclo[3.3.1]nonane-9-carboxylate 
• 1148006-34-1 (1R,5S,7S)-9-benzyl-3-oxa-9-azabicyclo[3.3.1]nonan-7-ol 
• 1148006-31-8 (1R,5S,7S)-tert-butyl 7-hydroxy-3-oxa-9-azabicyclo[3.3.1]nonane-9-carboxylate 

Relevant articles and documents

SUBSTITUENT-INCLUDING UREA COMPOUND

An object of the present invention is to provide a compound that has a specific chemical structure having an activation effect on SIRT6 and is useful as an active component for preventing and treating inflammatory diseases. The present invention relates to a compound represented by Formula (1) or a pharmaceutically acceptable salt thereof. (Each symbol in Formula (1) has the same definition as that described in the specification.)

SUBSTITUTED BRIDGED DIAZEPANE DERIVATIVES AND USE THEREOF

The present application relates to novel imidazopyridinyl-or imidazopyrimidinyl-substituted, bridged 1,4-diazepane derivatives, to processes for their preparation, to their use alone or in combinations for the treatment and/or prevention of diseases, and to their use for preparing medicaments for the treatment and/or prevention of diseases, in particular for treatment and/or prevention of respiratory disorders including, sleep-related respiratory disorders such as obstructive sleep apnoeas and central sleep apnoeas and snoring.

6-BRIDGED HETEROARYLDIHYDROPYRIMIDINES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION

The invention provides novel compounds having the general formula: wherein R1, R2, R3 and R4 are as defined in the description and in the claims, as well as or pharmaceutically acceptable salts, or tautomerism isomers, or enantiomers, or diastereomers thereof. The invention also contains compositions including the compounds and methods of using the compounds for the treatment or prophylaxis of hepatitis B virus infection.